NCT06847191

NE3107 in Adults With Neurological Symptoms of Long COVID

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2025-04-29Est. Completion: 2026-08-06

Enrollment target: 203 participants

Locations

Stanford University, Palo Alto, California, United States
UCSF, San Francisco, California, United States
University of Colorado, Aurora, Colorado, United States
Yale University, New Haven, Connecticut, United States
Clinical Trial Site, Jacksonville, Florida, United States
Centricity Research, Columbus, Georgia, United States
Illinois Research Network University of Illinois at Chicago, Chicago, Illinois, United States
Northwestern University, Chicago, Illinois, United States
University of Iowa, Iowa City, Iowa, United States
Norton Infectious Disease Institute, Louisville, Kentucky, United States
Jadestone Clinical Research, Silver Spring, Maryland, United States
Clinical Trial Site, Farmington Hills, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Zenos Clinical Research, Dallas, Texas, United States

Orthopedic Disorder

Total knee replacement (TKR) is a successful and cost-effective treatment for end-stage arthritis. Its usage is increasi…

Leeds, United KingdomEst. completion Sep 1, 2026

Post-Acute COVID-19 Syndrome

Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from an acute COVID-19 infection may …

Bethesda, United StatesEst. completion Jan 1, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.